Header Logo

ROHIT SRIVASTAVA

TitleInstructor
InstitutionBaylor College of Medicine
DepartmentDepartment of Molecular & Cellular Biology
AddressOne Baylor Plaza
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Srivastava SP, Kopasz-Gemmen O, Thurman A, Rajendran BK, Selvam MM, Kumar S, Srivastava R, Suresh MX, Kumari R, Goodwin JE, Inoki K. The molecular determinants regulating redox signaling in diabetic endothelial cells. Front Pharmacol. 2025; 16:1563047. PMID: 40290438; PMCID: PMC12023289.
      Citations: 1     
    2. Prasad R, Ghosh A, Patel V, Peng B, Mendes BB, Win EHA, Delogu LG, Wong JY, Pischel KJ, Bellare JR, Bar-Shir A, Thakor AS, Parak WJ, Bhujwalla ZM, Zhang YS, Kommineni N, Rotello VM, Cai W, Lammers T, Odom TW, Padmanaban G, Peer D, Lovell JF, Srivastava R, Langer R, Conde J. Voices of Nanomedicine: Blueprint Guidelines for Collaboration in Addressing Global Unmet Medical Needs. ACS Nano. 2025 01 28; 19(3):2979-2991. PMID: 39792961; PMCID: PMC12412050.
      Citations: 1     Fields:    Translation:HumansCells
    3. Jain NK, Pallod S, Peng B, Kumari R, Chauhan DS, Dhanka M, Aung Win EH, Teitell MA, Chandra P, Srivastava R, Prasad R. Stimuli Responsive Molecular Exchange of Structure Directing Agents on Gold Nanobipyramids: Cancer Cell Detection and Synergistic Therapeutics. ACS Appl Bio Mater. 2024 07 15; 7(7):4542-4552. PMID: 38957152.
      Citations:    
    4. Espinoza AF, Patel RH, Patel KR, Badachhape AA, Whitlock R, Srivastava RK, Govindu SR, Duong A, Kona A, Kureti P, Armbruster B, Kats D, Srinivasan RR, Dobrolecki LE, Yu X, Najaf Panah MJ, Zorman B, Sarabia SF, Urbicain M, Major A, Bissig KD, Keller C, Lewis MT, Heczey A, Sumazin P, L?pez-Terrada DH, Woodfield SE, Vasudevan SA. A novel treatment strategy utilizing panobinostat for high-risk and treatment-refractory hepatoblastoma. J Hepatol. 2024 04; 80(4):610-621. PMID: 38242326.
      Citations: 3     Fields:    Translation:HumansAnimals
    5. Woodfield SE, Mistretta BJ, Patel RH, Ibarra AM, Fisher KE, Sarabia SF, Gandhi I, Reuther J, Starosolski Z, Badachhape A, Epps J, Zorman B, Shah AP, Larson SR, Srivastava RK, Shi Y, Espinoza AF, Govindu SR, Whitlock RS, Holloway K, Roy A, Sumazin P, Ghaghada KB, Lopez-Terrada D, Gunaratne PH, Vasudevan SA. HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells. Biol Open. 2022 09 15; 11(9). PMID: 35451474; PMCID: PMC9493725.
      Citations:    Fields:    
    6. Bhat SK, Srivastava A, Ansari NA, Rai P, Singh RP, Srivastava R, Roy AK, Fatima J. Emphysematous Pyelonephritis in Type 2 Diabetes - Clinical Profile and Management. Saudi J Kidney Dis Transpl. 2021 Nov-Dec; 32(6):1646-1654. PMID: 35946277.
      Citations:    
    7. Woodfield SE, Shi Y, Patel RH, Chen Z, Shah AP, Srivastava RK, Whitlock RS, Ibarra AM, Larson SR, Sarabia SF, Badachhape A, Starosolski Z, Ghaghada KB, Sumazin P, Annis DA, Vasudevan SA, L?pez-Terrada D. Author Correction: MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma. Sci Rep. 2021 Oct 01; 11(1):19916. PMID: 34599198; PMCID: PMC8486835.
      Citations:    Fields:    
    8. Chauhan DS, Dhasmana A, Laskar P, Prasad R, Jain NK, Srivastava R, Jaggi M, Chauhan SC, Yallapu MM. Nanotechnology synergized immunoengineering for cancer. Eur J Pharm Biopharm. 2021 Jun; 163:72-101. PMID: 33774162; PMCID: PMC8170847.
      Citations:    
    9. Woodfield SE, Shi Y, Patel RH, Chen Z, Shah AP, Srivastava RK, Whitlock RS, Ibarra AM, Larson SR, Sarabia SF, Badachhape A, Starosolski Z, Ghaghada KB, Sumazin P, Annis DA, Vasudevan SA, L?pez-Terrada D. MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma. Sci Rep. 2021 02 03; 11(1):2967. PMID: 33536467; PMCID: PMC7859402.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    10. Prasad R, Jain NK, Yadav AS, Jadhav M, Radharani NNV, Gorain M, Kundu GC, Conde J, Srivastava R. Ultrahigh Penetration and Retention of Graphene Quantum Dot Mesoporous Silica Nanohybrids for Image Guided Tumor Regression. ACS Appl Bio Mater. 2021 02 15; 4(2):1693-1703. PMID: 35014516.
      Citations:    
    11. Singh P, Srivastava RK. Stem cell therapies as a therapeutic option to counter chemo brain: a negative effect of cancer treatment. Regen Med. 2020 06; 15(6):1789-1800. PMID: 32844724.
      Citations: 1     Fields:    Translation:HumansCells
    12. Chauhan DS, Prasad R, Srivastava R, Jaggi M, Chauhan SC, Yallapu MM. Comprehensive Review on Current Interventions, Diagnostics, and Nanotechnology Perspectives against SARS-CoV-2. Bioconjug Chem. 2020 09 16; 31(9):2021-2045. PMID: 32680422; PMCID: PMC7425040.
      Citations:    
    13. Prasad R, Jain NK, Yadav AS, Chauhan DS, Devrukhkar J, Kumawat MK, Shinde S, Gorain M, Thakor AS, Kundu GC, Conde J, Srivastava R. Liposomal nanotheranostics for multimode targeted in vivo bioimaging and near-infrared light mediated cancer therapy. Commun Biol. 2020 06 05; 3(1):284. PMID: 32504032; PMCID: PMC7275035.
      Citations:    
    SRIVASTAVA's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (76)
    Explore
    _
    Co-Authors (12)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _